When to Treat First in Metastatic NSCLC?

• by Jo Cavallo

• January 13, 2026

NHS-Galleri Linked to Delays

Analysis of England’s multicancer early detection screening trial found modest, temporary diagnostic delays in participating regions, adding to concerns about health system effects and the evidence base for population-level blood-based cancer screening.

• by Andrea Surnit

• June 4, 2026

• 6 min

Repeatability of AI-quantified incidental findings on lung cancer screening CT scans in the NELSON trial

• by Stijn Bunk, Thijs Bruins Slot, Edwin Bennink, Grigory Sidorenkov, Nils van der Velden, Niels Schurink, Félix Lades, Markus Sebald, Marjolein A. Heuvelmans, Hester A. Gietema, Joachim G. Aerts, Geertruida H. de Bock, Cornelia Schaefer-Prokop, Pim A. de Jong, Rozemarijn Vliegenthart, Firdaus A. A. Mohamed Hoesein

• June 17, 2026

First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study

• by Wan Zhang, Xiaojun Yang, Hualin Chen, Xingxiang Pu, Reyihanguli Tuohetashi, Xuan Wu, Zhanhong Xie, Di Wu, Yongguang Cai, Shi Jin, Xuli Guo, Kaitao Yao, Yongfeng Chen, Guanming Jiang

• June 8, 2026